Patents by Inventor Alexander Litovchick

Alexander Litovchick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11674135
    Abstract: The present invention relates to complexes of oligonucleotide-encoded libraries and methods of tagging and using such libraries. In particular, the oligonucleotides and methods can include complexes having at least one linkage for which a polymerase has reduced ability to read or translocate through.
    Type: Grant
    Filed: July 12, 2013
    Date of Patent: June 13, 2023
    Assignee: X-Chem, Inc.
    Inventors: Anthony D. Keefe, Alexander Litovchick, Matthew Clark
  • Publication number: 20220251600
    Abstract: Described herein are recombinant vectors and methods for their use in expressing recombinant proteins in both insect and mammalian cells. The invention is based on recombinant transfer vectors that enable expression of one or more transgenes to be directed by an insect cell-competent promoter and a mammalian cell-competent promoter, both present within a single expression cassette in the vector, and active conditional on the host cell.
    Type: Application
    Filed: June 25, 2020
    Publication date: August 11, 2022
    Inventors: Alexander LITOVCHICK, Ragunath CHANDRAN, Moritz VON RECHENBERG, John CUOZZO
  • Patent number: 11268090
    Abstract: The invention provides methods and compositions useful for identifying polypeptides with desired characteristics in vitro.
    Type: Grant
    Filed: November 8, 2019
    Date of Patent: March 8, 2022
    Assignee: X-BODY, INC.
    Inventors: Richard W. Wagner, Alexander Litovchick, Yan Chen
  • Publication number: 20210002630
    Abstract: The present invention relates to oligonucleotide-encoded libraries and methods of tagging such libraries. In particular, the methods and oligonucleotides can include one or more 2?-substituted nucleotides, such as 2?-O-methyl or 2?-fluoro nucleotides, and other conditions or reagents to enhance enzyme ligation or one or more chemical functionalities to support chemical ligation.
    Type: Application
    Filed: May 7, 2020
    Publication date: January 7, 2021
    Inventors: Anthony D. KEEFE, Richard W. WAGNER, Alexander LITOVCHICK, Matthew CLARK, John CUOZZO, Ying ZHANG, Paolo A. CENTRELLA, Christopher D. HUPP
  • Patent number: 10865409
    Abstract: The present invention relates to oligonucleotide-encoded libraries and methods of tagging such libraries. In particular, the methods and oligonucleotides can include one or more 2?-substituted nucleotides, such as 2?-O-methyl or 2?-fluoro nucleotides, and other conditions or reagents to enhance enzyme ligation or one or more chemical functionalities to support chemical ligation.
    Type: Grant
    Filed: September 7, 2012
    Date of Patent: December 15, 2020
    Assignee: X-Chem, Inc.
    Inventors: Anthony D. Keefe, Richard W. Wagner, Alexander Litovchick, Matthew Clark, John W. Cuozzo, Ying Zhang, Paolo A. Centrella, Christopher D. Hupp
  • Publication number: 20200172897
    Abstract: The invention provides methods and compositions useful for identifying polypeptides with desired characteristics in vitro.
    Type: Application
    Filed: November 8, 2019
    Publication date: June 4, 2020
    Inventors: Richard W. Wagner, Alexander Litovchick, Yan Chen
  • Patent number: 10519438
    Abstract: The invention provides methods and compositions useful for identifying polypeptides with desired characteristics in vitro.
    Type: Grant
    Filed: September 13, 2017
    Date of Patent: December 31, 2019
    Assignee: X-BODY, INC.
    Inventors: Richard W. Wagner, Alexander Litovchick, Yan Chen
  • Publication number: 20180094256
    Abstract: The invention provides methods and compositions useful for identifying polypeptides with desired characteristics in vitro.
    Type: Application
    Filed: September 13, 2017
    Publication date: April 5, 2018
    Inventors: Richard W. Wagner, Alexander Litovchick, Yan Chen
  • Publication number: 20180002688
    Abstract: The present invention relates to methods for producing encoded chemical entities. In particular, the oligonucleotides and methods can include encoded chemical entities having wild-type linkages formed through chemical ligation techniques. One strategy that can be utilized that simultaneously takes advantage of chemical ligation as a means to encode chemical history, while also retaining the ability of polymerases to directly recover tag sequence and association information, is to perform chemical ligation in a manner that generates wildtype phosphodiester linkages. Such methods generally utilize condensing agents such as cyanogen bromide or similar along with 5?-phosphate and 3?-hydroxyl oligonucleotides in a double-stranded or templated context. Similarly cyanogen bromide has also been shown to chemically ligate pairs of substrate oligonucleotides that are 5?-hydroxyl and 3?-phosphate.
    Type: Application
    Filed: December 28, 2015
    Publication date: January 4, 2018
    Applicant: X-Chem, Inc.
    Inventors: Anthony D. KEEFE, Alexander LITOVCHICK, Matthew CLARK, Richard W. WAGNER
  • Patent number: 9803193
    Abstract: The invention provides methods and compositions useful for identifying polypeptides with desired characteristics in vitro.
    Type: Grant
    Filed: July 10, 2015
    Date of Patent: October 31, 2017
    Assignee: X-BODY, INC.
    Inventors: Richard W. Wagner, Alexander Litovchick, Yan Chen
  • Publication number: 20160040158
    Abstract: The invention provides methods and compositions useful for identifying polypeptides with desired characteristics in vitro.
    Type: Application
    Filed: July 10, 2015
    Publication date: February 11, 2016
    Inventors: Richard W. Wagner, Alexander Litovchick, Yan Chen
  • Patent number: 9134304
    Abstract: The invention provides methods and compositions useful for identifying polypeptides with desired characteristics in vitro.
    Type: Grant
    Filed: January 19, 2011
    Date of Patent: September 15, 2015
    Assignee: X-Body, Inc.
    Inventors: Richard W. Wagner, Alexander Litovchick, Yan Chen
  • Publication number: 20150211002
    Abstract: The present invention relates to complexes of oligonucleotide-encoded libraries and methods of tagging and using such libraries. In particular, the oligonucleotides and methods can include complexes having at least one linkage for which a polymerase has reduced ability to read or translocate through.
    Type: Application
    Filed: July 12, 2013
    Publication date: July 30, 2015
    Inventors: Anthony D. Keefe, Alexander Litovchick, Matthew Clark
  • Publication number: 20140315762
    Abstract: The present invention relates to oligonucleotide-encoded libraries and methods of tagging such libraries. In particular, the methods and oligonucleotides can include one or more 2?-substituted nucleotides, such as 2?-O-methyl or 2?-fluoro nucleotides, and other conditions or reagents to enhance enzyme ligation or one or more chemical functionalities to support chemical ligation.
    Type: Application
    Filed: September 7, 2012
    Publication date: October 23, 2014
    Applicant: X-Chem, Inc.
    Inventors: Anthony D. Keefe, Richard W. Wagner, Alexander Litovchick, Matthew Clark, John W. Cuozzo, Ying Zhang, Paolo A. Centrella, Christopher D. Hupp
  • Publication number: 20110183863
    Abstract: The invention provides methods and compositions useful for identifying polypeptides with desired characteristics in vitro.
    Type: Application
    Filed: January 19, 2011
    Publication date: July 28, 2011
    Applicant: X-BODY BIOSCIENCES
    Inventors: Richard W. WAGNER, Alexander LITOVCHICK
  • Patent number: 6642365
    Abstract: Conjugates of a saccharide and an acetamidino- or guanidino-compound, of the formula: wherein A is CH3 or NH2; X is a linear or branched C1-C8 alkyl chain optionally containing hydroxy, amino and/or oxo groups; n is an integer from 1 to 6, and Sac is the residue of a mono-or oligo-saccharide, provided that when A is NH2 and X is -(CH2)3—CH(NH2)—C(=O)-, the monosaccharide residue is not substituted at the position 1, and n is an integer from 2 to 6 when Sac is the residue of an oligosaccharide, are useful as antiviral, particularly as antiretroviral, agents, and can be used either alone or together with other compounds used in AIDS treatment such as AZT and/or protease inhibitors, for the treatment of HIV-infection, AIDS and manifestations of AIDS such as Kaposi sarcoma.
    Type: Grant
    Filed: June 28, 2001
    Date of Patent: November 4, 2003
    Assignee: Yeda Research and Development Co. Ltd.
    Inventors: Aviva Lapidot, Alexander Litovchick, Artem G. Evdokimov